Beyond its role as a microtubule inhibitor, the inhibition of TERT-RdRP (measured with a specific immunoprecipitation–RdRP assay) may contribute to Eribulin’s potent anti-GBM effects [32]. This evidence concerns the gene TERT and glioblastoma.